Home  /  Resource Library  /  Reducing and controlling metabolic active tumor volume prior to CAR T-cell infusion can improve survival outcomes in patients with large B-cell lymphoma

Reducing and controlling metabolic active tumor volume prior to CAR T-cell infusion can improve survival outcomes in patients with large B-cell lymphoma

Study investigated metabolic tumour volume prior to CAR T treatment and prognosis in patients with DLBCL.